Josh Lewis is a senior commercial manager for Cold Storage Products at Thermo Fisher Scientific. Having been in the laboratory products industry for the last 13 years, Lewis has experienced cold storage from multiple lenses including R&D as well as global product and commercial management. He holds...
60 Clinicopathological Prognostic Indicators of Solitary Fibrous Tumor Jimin Kim, Yoonla Choi. Samsung Medical Center, Seoul, Republic of Korea. Background: Solitary fibrous tumors(SFTs) are uncommon spindle-cell mesenchymal tumors, which are classified as having intermediate biological potential in the ...
Background: Progress in treatment of HCRM demands pathologic indicators of therapy response. Pathologic response;one of the best predictor of disease free survival (DFS) has limitation of low reproducibly among pathologists. Based on observation of majority of residual tumor cells seen at the TNI, ...
1360 Cell of Origin Subtype Determined by Immunohistochemistry and MYC and BCL2 Dual Expression in DLBCL as Potential Prognostic Indicators AMB Collie, BT Hill, ED Hsi. Cleveland Clinic, Cleveland, OH. Background: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease entity with ...
Conclusions: In summary, loss of nuclear expression and intense cytoplasmic FGFR- 3 expression correlate with hormone receptor status and are independent prognostic indicators in BRCA. Further study of FGFR-3 as a prognostic factor and potential target of therapy in BRCA appears warranted. 101 ...
Background: PAX2 and PAX8 are transcription factors involved in embryogenesis that have been utilized as immunohistochemical indicators of tumor origin. Specifically, PAX2 is a marker of neoplasms of renal and Müllerian origin, while PAX8 is expressed by renal, Müllerian, and thyroid tumors. While...